Indoco Remedies informs about company updates

07 Sep 2016 Evaluate

Indoco Remedies has informed that USFDA inspected the Company’s Goa Plant II from August 31, 2016 to September 04, 2016. The injectable ANDA filings triggered this inspection. At the end of the inspection, six 483s were issued. All the observations (483s) are correctable and the Company expects to complete the corrective and preventive actions within a period of 30 days. None of the 483s are related to Data Integrity issue.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

229.80 3.25 (1.43%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×